Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Diwei, Zheng"'
Publikováno v:
Shanghai Jiaotong Daxue xuebao, Vol 57, Iss 8, Pp 1067-1077 (2023)
In order to improve the energy harvesting efficiency of the wind energy capture structure, this paper proposes a novel wavy conical bladeless wind energy capture structure, and establishes a mathematical model for energy conversion of the wavy conica
Externí odkaz:
https://doaj.org/article/d2849a2d4e45430086275cef4c1b4827
Autor:
Jiang Lv, Le Qin, Ruocong Zhao, Di Wu, Zhiping Wu, Diwei Zheng, Siyu Li, Mintao Luo, Qiting Wu, Youguo Long, Zhaoyang Tang, Yan-Lai Tang, Xuequn Luo, Yao Yao, Li-Hua Yang, Peng Li
Publikováno v:
Molecular Therapy: Oncolytics, Vol 28, Iss , Pp 46-58 (2023)
Tumor cells and the immunosuppressive tumor microenvironment suppress the antitumor activity of T cells through immune checkpoints, including the PD-L1/PD-1 axis. Cytokine-inducible SH2-containing protein (CISH), a member of the suppressor of cytokin
Externí odkaz:
https://doaj.org/article/1adeb91ca0b54373b88030ea4ef4a683
Autor:
Yuanbin Cui, Tingjie Yuan, Ying Wang, Diwei Zheng, Le Qin, Shanglin Li, Zhiwu Jiang, Shouheng Lin, Wenjing Guo, Zhi Wang, Zhaoduan Liang, Yi Li, Yao Yao, Xingguo Liu, Qiannan Tang, Hai-Yan Tu, Xu-Chao Zhang, Zhaoyang Tang, Nathalie Wong, Zhenfeng Zhang, Dajiang Qin, Jean Paul Thiery, Kailin Xu, Peng Li
Publikováno v:
Cell Reports, Vol 42, Iss 7, Pp 112797- (2023)
Summary: Chimeric antigen receptor (CAR) T cell therapy lacks persistent efficacy with “on-target, off-tumor” toxicities for treating solid tumors. Thus, an antibody-guided switchable CAR vector, the chimeric Fc receptor CD64 (CFR64), composed of
Externí odkaz:
https://doaj.org/article/19026a5a9b9f441696fdcf97f3be7fbe
Autor:
Zhiwu Jiang, Le Qin, Yuou Tang, Rui Liao, Jingxuan Shi, Bingjia He, Shanglin Li, Diwei Zheng, Yuanbin Cui, Qiting Wu, Youguo Long, Yao Yao, Zhihui Wei, Qilan Hong, Yi Wu, Yuanbang Mai, Shixue Gou, Xiaoping Li, Robert Weinkove, Sam Norton, Wei Luo, Weineng Feng, Hongsheng Zhou, Qifa Liu, Jiekai Chen, Liangxue Lai, Xinwen Chen, Duanqing Pei, Thomas Graf, Xingguo Liu, Yangqiu Li, Pentao Liu, Zhenfeng Zhang, Peng Li
Publikováno v:
Biomarker Research, Vol 10, Iss 1, Pp 1-22 (2022)
Abstract Background Adoptive cell therapy (ACT) is a particularly promising area of cancer immunotherapy, engineered T and NK cells that express chimeric antigen receptors (CAR) are being explored for treating hematopoietic malignancies but exhibit l
Externí odkaz:
https://doaj.org/article/05d264f1064e4fdda9f2bdf26d6a951c
Autor:
Diwei Zheng, Weihai Liu, Wenlin Xie, Guanyu Huang, Qiwei Jiang, Yang Yang, Jiarong Huang, Zihao Xing, Mengling Yuan, Mengning Wei, Yao Li, Junqiang Yin, Jingnan Shen, Zhi Shi
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-12 (2021)
Abstract Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents. Although activator of HSP90 ATPase activity 1 (AHA1) is reported to be a potential oncogene, its role in osteosarcoma progression remains largely
Externí odkaz:
https://doaj.org/article/5ed2f433cbfe4e318fc1e650137569fa
The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell Malignancies
Autor:
Diwei Zheng, Xindong Wang, Lin Cheng, Le Qin, Zhiwu Jiang, Ruocong Zhao, Yao Li, Jingxuan Shi, Qiting Wu, Youguo Long, Suna Wang, Zhaoyang Tang, Wei Wei, Jie Yang, Yangqiu Li, Hongsheng Zhou, Qifa Liu, Pentao Liu, Xinwen Chen, Yao Yao, LiHua Yang, Peng Li
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Chimeric antigen receptor (CAR) T cells have been successfully used in the therapy of B cell leukemia and lymphoma, but still have many challenges in their use for treating T cell malignancies, such as the lack of unique tumor antigens, their limitat
Externí odkaz:
https://doaj.org/article/0dc41a68546941458d6ffed9c0611970
Autor:
Di Wu, Jiang Lv, Ruocong Zhao, Zhiping Wu, Diwei Zheng, Jingxuan Shi, Simiao Lin, Suna Wang, Qiting Wu, Youguo Long, Peng Li, Yao Yao
Publikováno v:
Biomarker Research, Vol 8, Iss 1, Pp 1-11 (2020)
Abstract Background Gastric cancer is a deadly malignancy and is a prognostically unfavorable entity with restricted therapeutic strategies available. Prostate stem cell antigen (PSCA) is a glycosylphosphatidylinositol (GPI)-anchored cell surface pro
Externí odkaz:
https://doaj.org/article/2f603940f8da4264b3bf2d33a0c99a2c
Autor:
Jiang Lv, Ruocong Zhao, Di Wu, Diwei Zheng, Zhiping Wu, Jingxuan Shi, Xinru Wei, Qiting Wu, Youguo Long, Simiao Lin, Suna Wang, Zhi Wang, Yang Li, Yantao Chen, Qing He, Suimin Chen, Huihui Yao, Zixia Liu, Zhaoyang Tang, Yao Yao, Duanqing Pei, Pentao Liu, Xuchao Zhang, Zhenfeng Zhang, Shuzhong Cui, Ren Chen, Peng Li
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-14 (2019)
Abstract Background Gastric cancer (GC) is a common cancer in Asia and currently lacks a targeted therapy approach. Mesothelin (MSLN) has been reported to be expressed in GC tissue and could be targeted by chimeric antigen receptor (CAR) T cells. Mes
Externí odkaz:
https://doaj.org/article/ff188493c8c44fc3bf8bda14f41783e9
Autor:
Ji-Yan Qiao, Run-Yao Zeng, Qi-Wen Chen, Diwei Zheng, Pei-Ling Hao, Xin-Hua Liu, Faqiong Zhao, Xian-Zheng Zhang
Publikováno v:
Nano Letters. 23:4375-4383
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::419e36e99c1d590236ecb353506b40b5
https://doi.org/10.1021/acs.nanolett.3c00657
https://doi.org/10.1021/acs.nanolett.3c00657
Autor:
Shouheng Lin, Lin Cheng, Wei Ye, Shanglin Li, Diwei Zheng, Le Qin, Qiting Wu, Youguo Long, Simiao Lin, Suna Wang, Guohua Huang, Peng Li, Yao Yao, Xiaofang Sun
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The adoptive transfer of chimeric antigen receptor T (CAR T) cells have been recognized as a promising therapeutic strategy for the treatment of hematological malignancies; however, clinical success using CAR T cells for the treatment of solid tumors
Externí odkaz:
https://doaj.org/article/9b764542fed049aa9b1137864a9dc5df